Ordinary Index Rebalancing in the Solactive Pharma & Biotech Opportunity Index | August 2021

In the ordinary rebalance the following composition will be implemented effective open 19.08.2021:

3SBIO INC
ABCAM PLC
AGIOS PHARMACEUTICALS INC
ALMIRALL SA
ARCUS BIOSCIENCES INC
ARGENX SE
BAVARIAN NORDIC A/S
BIOMARIN PHARMACEUTICAL INC
CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS LTD
CHINA MEDICAL SYSTEM HOLDINGS LTD
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD
CORCEPT THERAPEUTICS INC
CSPC PHARMACEUTICAL GROUP LTD
EDITAS MEDICINE INC
EMERGENT BIOSOLUTIONS INC
EXELIXIS INC
GALAPAGOS NV
HIKMA PHARMACEUTICALS PLC
IPSEN SA
JAZZ PHARMACEUTICALS PLC
NEKTAR THERAPEUTICS
NIPPON SHINYAKU CO LTD
ONENESS BIOTECH CO LTD
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT.
SEEGENE INC
SIMCERE PHARMACEUTICAL GROUP
SINO BIOPHARMACEUTICAL LTD ORD
SWEDISH ORPHAN BIOVITRUM AB
TAKARA BIO INC
VIFOR PHARMA AG